Enterprise AI is moving from a software feature to a broader corporate strategy, and this week’s developments on the New York Stock Exchange Trading Floor highlight three parts of that transition: AI-powered work delegation, workforce intelligence and the infrastructure required to run increasingly demanding models. The enterprise AI market is entering a phase where the…
Enterprise software procurement was designed around relatively predictable units: users, licenses and subscriptions. Agentic AI is disrupting that assumption. A single employee prompt can trigger tool calls, model switches, retries, background APIs and multi-agent tasks—turning an apparently simple interaction into a chain of potentially billable events. The rise of agentic AI is creating a new…
Enterprise AI is entering a less glamorous but increasingly important phase: making sense of the documents, files and fragmented data that sit underneath everyday business processes. Singapore-based fileAI is targeting that layer with fresh backing from SMBC Asia Rising Fund and Singtel Innov8, alongside the launch of its fileScout unstructured-data mapping technology. The investment announced…
Developing more efficient green hydrogen systems can require engineers to run thousands of computationally expensive simulations before finding a useful operating point. Researchers in South Korea have demonstrated a different approach: an AI-guided optimization framework for solid oxide electrolysis cells (SOECs) that achieved its reported optimization results using just 17 high-fidelity computational fluid dynamics simulations….
Viva Biotech is increasing its investment in AI-driven drug discovery as pharmaceutical research moves toward workflows that combine computational design with laboratory validation. The Hong Kong-listed biotech services group reported RMB1.01 billion in first-half 2026 revenue, up 21% year over year, while expanding its AI-enabled discovery platform and advancing commercial CDMO projects. Viva Biotech Pushes…
